AI Article Synopsis
- G6PD deficiency is a widespread hereditary enzyme defect affecting over 400 million people and can lead to serious health issues like hemolytic anemia.
- This study introduces a new high-throughput quantitative method for measuring G6PD activity, improving on traditional screening techniques.
- The innovative approach allows for direct blood analysis from collection tubes, significantly cutting down on both time and costs associated with the testing process.
Article Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common hereditary enzyme defect that affects over 400 million people worldwide. Deficiency in G6PD can cause hemolytic anemia, which can be fatal if it is not treated properly. Mass qualitative G6PD-deficiency screening methods have been available for some time; however, in this study we developed the first high-throughput quantitative method for measuring G6PD activity. A patient's blood can be analyzed directly from the original collection tubes on a Hitachi P modular serum work area (SWA), which dramatically reduces the analysis time and the cost of the assay. The results presented here may enable the development of other improved, automated assays of whole-blood samples.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649015 | PMC |
| http://dx.doi.org/10.1002/jcla.20117 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!